261 related articles for article (PubMed ID: 23802234)
1. Developments in the use of nanocapsules in oncology.
Yurgel V; Collares T; Seixas F
Braz J Med Biol Res; 2013 Jun; 46(6):486-501. PubMed ID: 23802234
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology based targeted drug delivery.
Ruggiero C; Pastorino L; Herrera OL
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3731-2. PubMed ID: 21096863
[TBL] [Abstract][Full Text] [Related]
3. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
Erdoğar N; Akkın S; Bilensoy E
Recent Pat Drug Deliv Formul; 2018; 12(4):252-266. PubMed ID: 30674269
[TBL] [Abstract][Full Text] [Related]
7. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
8. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
9. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
10. Toward therapeutic delivery with layer-by-layer engineered particles.
Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
[TBL] [Abstract][Full Text] [Related]
11. Nanooncology in ovarian cancer treatment.
Kasprzak B; Miskiel S; Markowska J
Eur J Gynaecol Oncol; 2016; 37(2):161-3. PubMed ID: 27172737
[TBL] [Abstract][Full Text] [Related]
12. Themed issue on Cancer Nanotechnology.
Grodzinski P
Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
[No Abstract] [Full Text] [Related]
13. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Update on current and potential nanoparticle cancer therapies.
Rink JS; Plebanek MP; Tripathy S; Thaxton CS
Curr Opin Oncol; 2013 Nov; 25(6):646-51. PubMed ID: 24097107
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine in veterinary oncology.
Lin TY; Rodriguez CO; Li Y
Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of chlorin e6 and doxorubicin using PEGylated hollow nanocapsules for 'all-in-one' tumor theranostics.
Li Q; Hou M; Ren J; Lu S; Xu Z; Li CM; Kang Y; Xue P
Nanomedicine (Lond); 2019 Sep; 14(17):2273-2292. PubMed ID: 31414615
[No Abstract] [Full Text] [Related]
18. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
19. Targeting liposomal nanomedicine to cancer therapy.
Zhong J; Dai LC
Technol Cancer Res Treat; 2012 Oct; 11(5):475-81. PubMed ID: 22475065
[TBL] [Abstract][Full Text] [Related]
20. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
